Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
卡帕替尼联合恩扎卢胺治疗多西他赛和阿比特龙治疗后的转移性去势抵抗性前列腺癌:来自随机 II 期 RE-AKT 试验的结果
期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2024.114103
Rescigno, Pasquale; Porta, Nuria; Finneran, Laura; Riisnaes, Ruth; Figueiredo, Ines; Carreira, Suzanne; Flohr, Penny; Miranda, Susana; Bertan, Claudia; Ferreira, Ana; Crespo, Mateus; Rodrigues, Daniel Nava; Gurel, Bora; Nobes, Jenny; Crabb, Simon; Malik, Zafar; Ralph, Christy; McGovern, Ursula; Hoskin, Peter; Jones, Robert J; Birtle, Alison; Gale, Joanna; Sankey, Peter; Jain, Suneil; McLaren, Duncan; Chadwick, Eliot; Espinasse, Aude; Hall, Emma; de Bono, Johann